Archemix Corp.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy (NCT00742612) | Archemix Corp. | 2009-02-01 |
| Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy (NCT00726544) | Archemix Corp. | 2008-12-01 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B (NCT00694785) | Archemix Corp. | 2008-10-01 |
| ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders (NCT00632242) | Archemix Corp. | 2008-01-01 |
| Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI (NCT00507338) | Archemix Corp. | 2007-10-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers (NCT00432770) | Archemix Corp. | 2006-12-01 |
Track Archemix Corp. automatically
Every clearance here is in the API, with alerts when new ones post.